-
EP3328998
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3328998
| EP3328998 - MUTATED FACTOR X POLYPEPTIDES AND USES THEREOF FOR THE TREATMENT OF HAEMOPHILIA [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 26.05.2023 Database last updated on 30.10.2024 | |
| Former | Examination is in progress Status updated on 22.04.2020 | ||
| Former | Request for examination was made Status updated on 04.05.2018 | ||
| Former | The international publication has been made Status updated on 03.02.2017 | Most recent event Tooltip | 26.05.2023 | Application deemed to be withdrawn | published on 28.06.2023 [2023/26] | Applicant(s) | For all designated states INSERM (Institut National de la Santé et de la Recherche Médicale) 101, rue de Tolbiac 75013 Paris / FR | For all designated states Universite Paris-Sud 15, rue Georges Clémenceau 91400 Orsay / FR | [2018/23] | Inventor(s) | 01 /
CHRISTOPHE, Olivier INSERM U 1176 Paris-Sud 80 Rue du Général Leclerc 94276 Le Kremlin-Bicetre / FR | 02 /
DENIS, Cécile INSERM U 1176 Paris-Sud 80 Rue du Général Leclerc 94276 Le Kremlin-Bicetre / FR | 03 /
LENTING, Peter INSERM U 1176 Paris-Sud 80 Rue du Général Leclerc 94276 Le Kremlin-Bicetre / FR | [2018/23] | Representative(s) | Inserm Transfert PariSanté Campus 10 rue d'Oradour-sur-Glane 75015 Paris / FR | [N/P] |
| Former [2018/23] | Collin, Matthieu Inserm-Transfert Paris Biopark 7, rue Watt 75013 Paris / FR | Application number, filing date | 16745690.4 | 26.07.2016 | [2018/23] | WO2016EP67826 | Priority number, date | EP20150306220 | 27.07.2015 Original published format: EP 15306220 | [2018/23] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2017017109 | Date: | 02.02.2017 | Language: | EN | [2017/05] | Type: | A1 Application with search report | No.: | EP3328998 | Date: | 06.06.2018 | Language: | EN | The application published by WIPO in one of the EPO official languages on 02.02.2017 takes the place of the publication of the European patent application. | [2018/23] | Search report(s) | International search report - published on: | EP | 02.02.2017 | Classification | IPC: | C12N9/64, C07K14/745, A61K38/36 | [2018/23] | CPC: |
C12N9/6432 (EP,US);
A61P7/04 (EP,US);
C12Y304/21006 (EP,US);
A61K38/00 (EP,US)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2018/23] | Title | German: | MUTIERTE FAKTOR X-POLYPEPTIDE UND VERWENDUNGEN DAVON ZUR BEHANDLUNG VON HÄMOPHILIE | [2018/23] | English: | MUTATED FACTOR X POLYPEPTIDES AND USES THEREOF FOR THE TREATMENT OF HAEMOPHILIA | [2018/23] | French: | POLYPEPTIDES MUTÉS DU FACTEUR X ET LEURS UTILISATIONS POUR LE TRAITEMENT DE L'HÉMOPHILIE | [2018/23] | Entry into regional phase | 24.01.2018 | National basic fee paid | 24.01.2018 | Designation fee(s) paid | 24.01.2018 | Examination fee paid | Examination procedure | 24.01.2018 | Amendment by applicant (claims and/or description) | 24.01.2018 | Examination requested [2018/23] | 24.01.2018 | Date on which the examining division has become responsible | 28.04.2020 | Despatch of a communication from the examining division (Time limit: M06) | 26.10.2020 | Reply to a communication from the examining division | 01.02.2023 | Application deemed to be withdrawn, date of legal effect [2023/26] | 21.02.2023 | Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time [2023/26] | Fees paid | Renewal fee | 24.07.2018 | Renewal fee patent year 03 | 22.07.2019 | Renewal fee patent year 04 | 22.07.2020 | Renewal fee patent year 05 | 20.07.2021 | Renewal fee patent year 06 | Penalty fee | Additional fee for renewal fee | 31.07.2022 | 07 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [YDA]WO2010070137 (INST NAT SANTE RECH MED [FR], et al) [YD] 4-6 * abstract *[A] 1,2,7-13; | [XY]US2014030247 (MADISON EDWIN L [US], et al) [X] 1,2,7-13 * abstract * [Y] 4-6 |